References
- Mowry JB, Spyker DA, Cantilena LR, Bailey JE, Ford M. 2012 Annual Report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 30th Annual Report. Clin Toxicol 2013; 51:949–1229.
- Prescott LF. Paracetamol overdosage: pharmacological considerations and clinical management. Drugs 1983; 25:290–314.
- Heydorn WE, Creed GJ, Wada H, Jacobowitz DM. Immunological evidence for existence of two subforms of soluble glutamic oxaloacetic transaminase (sGOT) in human and rat brain. Neurochem Int 1985; 5:833–841.
- Hayashi H, Wada H, Yoshimura T, Esaki N, Soda K. Recent topics in pyridoxal 5’-phosphate enzyme studies. Annu Rev Biochem 1990; 59:87–110.
- Lindblom P, Rafter I, Copley C, Andersson U, Hedberg JJ, Berg AL, et al. Isoforms of alanine aminotransferases in human tissues and serum – Differential tissue expression using novel antibodies. Arch Biochem Biophys 2007; 466:66–77.
- Liu L, Zhong S, Yang R, Hu H, Yu D, Zhu D, et al. Expression, purification, and initial characterization of human alanine aminotransferase (ALT) isoenzyme 1 and 2 in High-five insect cells. Prot Expr Purif 2008; 60:225–231.
- Dufour RD, Lott JA, Nolte FS, Gretch DR, Koff RS, Seeff LB. Diagnosis and monitoring of hepatic injury I. Performance characteristics of laboratory tests. Clin Chem 2000; 46:2027–2049.
- Curtis RM, Sivilotti M. A descriptive analysis of AST and ALT rise and fall following acetaminophen overdose. Clin Toxicol 2014; 52:697 (abstract).
- O’Grady JG, Alexander GJ, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989; 97:439–445.
- Johnson MT, McCammon CA, Mullins ME, Halcomb SE. Evaluation of a simplified N-acetylcysteine dosing regimen for the treatment of acetaminophen toxicity. Ann Pharmacother 2011; 45:713–720.